Work

FDG PET Biodistribution Patterns of Patients on GLP-1 Therapies

Year: 2026
Type: article
Study design: Observational Study
Abstract: PURPOSE: The use of glucagon-like peptide-1 (GLP-1) therapies continues to increase, but there is limited literature on their effect on fluorodeoxyglucose (FDG) biodistribution and minimal society guidelines. This study presents observations on a cohort of findings associated with GLP-1 use among patients undergoing oncologic FDG PET/CT, with attention to factors that may complicate image interpretation. MATERIALS AND METHODS: This retrospective observational study included 116 adult patients from a single academic center who reported use of a GLP-1. Medical information and demographic information were compiled, and images were analyzed for abnormal biodistribution. Statistical analysis was performed to determine association between these factors and atypical uptake. RESULTS: This study found areas of altered FDG biodistribution in 75.9% (88/116) of patients with uptake noted in the esophagus, small intestines, large intestines, and muscles. Muscle uptake was seen in 21.6% of patients including one patient whose scan was considered nondiagnostic. There was no significant association between muscle uptake and age, sex, BMI, time since last GLP-1 dose, NPO time, blood glucose level, individual GLP-1 medications, insulin usage, metformin usage, other antidiabetic drug usage, systemic steroid usage, or GI symptoms. However, there was a significant association with gastric solid contents (p value 0.01). CONCLUSIONS: This observational study found that patients using GLP-1 therapies exhibit multiple areas of altered biodistribution. Notably, increased muscle uptake had a statistically significant association with concomitant gastric solid contents. There was no association with fasting time (which ranged from 6 to 24 h in our sample). As patients were often on other medications, including other medications for diabetes, uptake may be related to a combination of factors. Further studies are needed to delve into the causes of altered biodistribution on FDG PET/CT performed on patients taking GLP-1s, with close attention to patients with muscle uptake, to inform future guidelines on image interpretation and patient preparation.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,190
OpenAlex ID: W7234036999
FWCI:
Cites: 13
Cited by:
Related to: 10